Insulin Dissociates the Effects of Liver X Receptor on Lipogenesis, Endoplasmic Reticulum Stress, and Inflammation
Overview
Authors
Affiliations
Diabetes is characterized by increased lipogenesis as well as increased endoplasmic reticulum (ER) stress and inflammation. The nuclear hormone receptor liver X receptor (LXR) is induced by insulin and is a key regulator of lipid metabolism. It promotes lipogenesis and cholesterol efflux, but suppresses endoplasmic reticulum stress and inflammation. The goal of these studies was to dissect the effects of insulin on LXR action. We used antisense oligonucleotides to knock down Lxrα in mice with hepatocyte-specific deletion of the insulin receptor and their controls. We found, surprisingly, that knock-out of the insulin receptor and knockdown of Lxrα produced equivalent, non-additive effects on the lipogenic genes. Thus, insulin was unable to induce the lipogenic genes in the absence of Lxrα, and LXRα was unable to induce the lipogenic genes in the absence of insulin. However, insulin was not required for LXRα to modulate the phospholipid profile, or to suppress genes in the ER stress or inflammation pathways. These data show that insulin is required specifically for the lipogenic effects of LXRα and that manipulation of the insulin signaling pathway could dissociate the beneficial effects of LXR on cholesterol efflux, inflammation, and ER stress from the negative effects on lipogenesis.
Molecular landscape of the overlap between Alzheimer's disease and somatic insulin-related diseases.
Ruisch I, Widomska J, De Witte W, Mota N, Fanelli G, van Gils V Alzheimers Res Ther. 2024; 16(1):239.
PMID: 39465382 PMC: 11514822. DOI: 10.1186/s13195-024-01609-2.
Rodimova S, Bobrov N, Mozherov A, Elagin V, Karabut M, Ermakova P Int J Mol Sci. 2023; 24(23).
PMID: 38069338 PMC: 10706954. DOI: 10.3390/ijms242317016.
FoxO-KLF15 pathway switches the flow of macronutrients under the control of insulin.
Takeuchi Y, Yahagi N, Aita Y, Mehrazad-Saber Z, Ho M, Huyan Y iScience. 2022; 24(12):103446.
PMID: 34988390 PMC: 8710527. DOI: 10.1016/j.isci.2021.103446.
Mertens J, De Block C, Spinhoven M, Driessen A, Francque S, Kwanten W Front Pharmacol. 2021; 12:768576.
PMID: 34759828 PMC: 8573337. DOI: 10.3389/fphar.2021.768576.
Jiang X, Zhang Y, Hu W, Liang Y, Zheng L, Zheng J Front Endocrinol (Lausanne). 2021; 12:651303.
PMID: 34054726 PMC: 8150005. DOI: 10.3389/fendo.2021.651303.